INTERNATIONAL VACCINE INSTITUTE: Form 990, tax year 2018

View the entire original 990 at ProPublica ↗

Organization
INTERNATIONAL VACCINE INSTITUTE (EIN 31-1621592)
Tax period
2018-01-01 to 2018-12-31
Filed
2019-07-29
IRS object ID
201902109349301210
Schema version
2018v3.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2019-07-29T14:12:01-05:00ReturnTs
Tax Period End2018-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1BDO USA LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line18401 GREENSBORO DRIVE 800AddressLine1Txt
CityMCLEANCityNm
State AbbreviationVAStateAbbreviationCd
ZIP22102ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2018-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN311621592EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1INTERNATIONAL VACCINE INSTITUTEBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% EUNHYE LEEInCareOfNm
Business Name ControlINTEBusinessNameControlTxt
Phone8228722803PhoneNum

Foreign Address ForeignAddress

FieldValueIRS element (for citing)
Address Line1snu research park 1 gwanak-roAddressLine1Txt
CityseoulCityNm
CountryKSCountryCd
Foreign Postal151-742ForeignPostalCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonFRANCOIS BELINPersonNm
Person TitleDEP DIR GENERAL, COOPersonTitleTxt
Phone7038930600PhoneNum
Signature2019-07-29SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonJacob CookPreparerPersonNm
PTINP01240455PTIN
Phone7038930600PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address4.15.233.162IPv4AddressTxt
FieldValueIRS element (for citing)
Federal Original Submission Id54621820192105000000FederalOriginalSubmissionId
Federal Original Submission Id2019-07-29FederalOriginalSubmissionIdDt
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device IdC44969C09172B32DC5279494C6AE8494327A5917AtSubmissionCreationDeviceId
At Submission Filing Device Id21113678E977CF0F147E11547FB84355093581B2AtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2018TaxYr
Build TS2019-02-21 02:37:17ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerJEROME H KIMPrincipalOfficerNm

Foreign Address ForeignAddress

FieldValueIRS element (for citing)
Address Line1SNU RESEARCH PARK 1 GWANAK-ROAddressLine1Txt
CitySEOULCityNm
CountryKSCountryCd
Foreign Postal151-742ForeignPostalCd
FieldValueIRS element (for citing)
Gross Receipts$30,267,343GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.ivi.intWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1997FormationYr
Activity Or MissionSEE SCHEDULE OActivityOrMissionDesc
Voting Members Governing Body14VotingMembersGoverningBodyCnt
Voting Members Independent13VotingMembersIndependentCnt
Total Employee1TotalEmployeeCnt
Total Volunteers14TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
PY Contributions Grants$27,484,411PYContributionsGrantsAmt
CY Contributions Grants$29,608,736CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$76,238PYInvestmentIncomeAmt
CY Investment Income$185,544CYInvestmentIncomeAmt
PY Other Revenue$235,868PYOtherRevenueAmt
CY Other Revenue$472,531CYOtherRevenueAmt
PY Total Revenue$27,796,517PYTotalRevenueAmt
CY Total Revenue$30,266,811CYTotalRevenueAmt
PY Grants And Similar Paid$7,865,415PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$8,993,323CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$10,302,629PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$10,893,841CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$425,286CYTotalFundraisingExpenseAmt
PY Other Expenses$7,774,133PYOtherExpensesAmt
CY Other Expenses$8,698,909CYOtherExpensesAmt
PY Total Expenses$25,942,177PYTotalExpensesAmt
CY Total Expenses$28,586,073CYTotalExpensesAmt
PY Revenues Less Expenses$1,854,340PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$1,680,738CYRevenuesLessExpensesAmt
Total Assets BOY$20,916,339TotalAssetsBOYAmt
Total Assets EOY$21,208,830TotalAssetsEOYAmt
Total Liabilities BOY$14,043,688TotalLiabilitiesBOYAmt
Total Liabilities EOY$12,798,045TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$6,872,651NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$8,410,785NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionSEE SCHEDULE OMissionDesc
Significant New Program SrvcYes (true)SignificantNewProgramSrvcInd
Significant ChangeYes (true)SignificantChangeInd
Expense$3,065,176ExpenseAmt
Grant$1,952,925GrantAmt
DescMERS-COV VACCINE DEVELOPMENT AGAINST MERS-COV SINCE IVI LAUNCHED THE MERS PROGRAM IN LATE 2015 WITH FUNDING FROM THE SAMSUNG LIFE PUBLIC WELFARE FOUNDATION, IVI CONTINUES TO WORK ON ACCELERATING THE DEVELOPMENT OF MERS VACCINES, WITH THE AIM OF DEMONSTRATING THE SAFETY AND IMMUNOGENICITY OF TWO MERS VACCINES IN PHASE II TRIALS CONDUCTED IN SOUTH KOREA. WITH IND APPROVAL BY THE KOREAN OF FOOD AND DRUG STFETY (KEFDS) IN 2017, IVI AND AND GENEONE LIFE SCIENCES CONTINUED COLLABORATION ON CONDUCTING THE PHASE I/IIA CLINICAL TRIALS OF GENEONE'S MERS DNA VACCINE CANDIDATE IN LATE 2018. UPON COMPLETION OF THE NEW TOXICITY STUDY,REQUIRED BY KMFDS AS PART OF THEIR IND APPROVAL,THE TRIAL INITIATED IN SEPTEMBER 2018, TARGETING COMPLETION OF SUBJECT ENROLLMENT BY JANUARY 2019. IVI ALSO KEPT ENGAGING WITH A DONOR AND VACCINE DEVELOPERS TO SELECT 2ND CANDIDATE MERS-COV VACCINE IN ADDITION TO GENEONE DNA VACCINE, THROUGH LANDSCAPE ANALYSIS. IN 2018, IVI WAS ACTIVELY INVOLVED IN AND LED DISCUSSION FOR COLLABORATION WITH POTENTIAL MANUFACTURING PARTNERS SUCH AS US-BASED NOVAVAX, UK-BASED VACCITECH AND KOREA-BASED SL VAXIGEN. OTHER THAN CLINICAL STUDIES, AN EPIDEMIOLOGICAL STUDY TO DEVELOP AND ANALYZE A DYNAMIC MODEL OF MERS-COV TRANSMISSION IN KOREA COMPLETEDIN DECEMBER 2018, WHICH WOULD SUPPORT THE KOREAN REGULATORY BODIES TO MAKE EFFECTIVE STRATEGIES ON MERS-COV VACCINATION AND VACCINE STOCKPILING. IVI HAS ALSO RENEWED THE PERIODIC PERMISSION FOR OPERATING BSL-3 FACILITIES FROM THE KOREA GOVERNMENT IN OCTOBER 2018, AND AFTER OBTAINING THE REGULATORY APPROVAL FOR HANDLING HIGH RISK PATHOGENS, IT HAS STORED WILD TYPE MERS-COV AND WOULD BE OPERATED FOR LABORATORY TESTING ON MERS-COV CLINICAL SAMPLES.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$2,780,913ExpenseAmt
Grant$1,205,369GrantAmt
DescSETA SEVERE TYPHOID IN AFRICA(SETA) SETA IS A FOLLOW-UP GRANT OF TSAP FUNDED BY THE BILL AND MELINDA GATES FOUNDATION. IT AIMS TO ESTIMATE THE BURDEN, SEVERITY, IMMUNE RESPONSE, LONG-TERM SEQUELAE AND THE ASSOCIATED COSTS OF INVASIVE SALMONELLA INFECTIONS IN SUB-SAHARAN AFRICA. NETWORK OF SURVEILLANCE SITES ACROSS 6 COUNTRIES IN SSA IS SET UP AND ACTIVITIES ARE ON-GOING IN ALL SETA COUNTRIES: MADAGASCAR (ANTANANARIVO, IMERINTSIATOSIKA), BURKINA FASO (OUAGADOUGOU, POLESGO, NIOKO), GHANA (AGOGO, KUMASI), NIGERIA (IBADAN), ETHIOPIA (ADAMA WENJI AND WELAYITA SODO), AND DRC (KISANTU.) AS OF DECEMBER 31, 2018, A TOTAL OF 318,076 PATIENTS HAD BEEN SCREENED FROM ALL PARTICIPATING SITES. FROM THESE SCREENED PATIENTS,12.5% (39,736/318,076) MET THE STUDY INCLUSION CRITERIA OF WHICH 40.6% (16,134/39,736) WERE ENROLLED IN SETADesc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$2,392,980ExpenseAmt
Grant$901,746GrantAmt
DescVi-DT clinical developmnet support for SK VI-DT CLINICAL DEVELOPMENT SUPPORT FOR SK CHEMICALS WE DEVELOPED A TYPHOID CONJUGATE VACCINE USING PLATFORM TECHNOLOGY FROM THE U.S. NATIONAL INSTITUTES OF HEALTH, CONJUGATING THE SALMONELLA TYPHI VI POLYSACCHARIDE TO DIPHTHERIA TOXOID (VI-DT). CONJUGATE VACCINES HAVE THE ADVANTAGE OF CONFERRING PROTECTION TO INFANTS (A HIGH-RISK GROUP) AGAINST TYPHOID AS WELL AS GENERATING T-CELL-BASED IMMUNE RESPONSES. IVI TRANSFERRED THIS TECHNOLOGY TO SK CHEMICALS IN SOUTH KOREA IN 2013 AND RECEIVED GRANTS FROM THE GATES FOUNDATION TO WORK WITH SK CHEMICALS (IVI IS LEADING CLINICAL DEVELOPMENT). THIS COLLABORATION AIMS TO OBTAIN VACCINE LICENSURE AND THEN RECEIVE WHO PREQUALIFICATION FOR PROCUREMENT IN THE GAVI/ UNICEF MARKET. - PHASE I CLINICAL TRIAL FOR SK VI-DT WAS COMPLETED IN MANILA, THE PHILIPPINES. THERE WERE 144 STUDY PARTICIPANTS ENROLLED. THE TRIAL SHOWED NO VACCINE SAFETY CONCERNS AND A 100% SEROCONVERSION RATE. - PHASE II CLINICAL TRIALS IS IN PROGRESS IN THE PHILIPPINES WITH TOTAL 285 STUDY PARTICIPANTS ENROLLED. - PREPARATORY ACTIVITIES ARE BEING CONDUCTED FOR PHASE III CLINICAL TRIALS IN NEPAL AND THE PHILIPPINES.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$15,000,599TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$4,933,282TotalOtherProgSrvcGrantAmt
Total Program Service Expenses$23,239,668TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesfalseLobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Temp Or Permanent EndowmentsfalseTempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnotefalseIncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtfalseConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficeYes (true)ForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgYes (true)MoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesfalseFundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingYes (true)LoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With Officer EntfalseBusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
Info In Schedule O Part VYes (X)InfoInScheduleOPartVInd
IRP Document0IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee1EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Foreign Financial AccountYes (true)ForeignFinancialAccountInd
Foreign CountryKSForeignCountryCd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsfalseQuidProQuoContributionsInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members14GoverningBodyVotingMembersCnt
Independent Voting Member13IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersYes (true)ElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyfalseForm990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonEUNHYE LEEPersonNm
Phone8228722803PhoneNum

Foreign Address ForeignAddress

FieldValueIRS element (for citing)
Address Line1snu research park 1 gwanak-roAddressLine1Txt
Province Or Stategwanak-gu, seoulProvinceOrStateNm
CountryKSCountryCd
Foreign Postal151-742ForeignPostalCd

Form990 Part VII Section A Form990PartVIISectionAGrp (23 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerIndKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
George Bickerstaff
Chairman / Board of Trustee1.00.0Yes (X)$1,592$0$0
George Siber
Director / Board of Trustee1.00.0Yes (X)$2,092$0$0
Joseph Kim
Director / Board of Trustee1.00.0Yes (X)$1,500$0$0
Hanna Nohynek
Director / Board of Trustee1.00.0Yes (X)$1,592$0$0
Fred Binka
Director / Board of Trustee1.00.0Yes (X)$1,684$0$0
Malcolm Sweeney
Director / Board of Trustee1.00.0Yes (X)$1,684$0$0
Jerome Kim
Director General40.00.0Yes (X)$618,648$0$153,414Yes (X)
Ralf Clemens
Director / Board of Trustee1.00.0Yes (X)$1,842$0$0
Takashima Yoshihiro
Director / Board of Trustee1.00.0Yes (X)$1,296$0$0
Lee Kyu Hyung
Director / Board of Trustee1.00.0Yes (X)$750$0$0
Chris Varma
DIRECTOR / BOARD OF TRUSTEE1.00.0Yes (X)$0$0$0
Shin Young Soo
DIRECTOR / BOARD OF TRUSTEE1.00.0Yes (X)$0$0$0
Kweon Ki-hwan
DIRECTOR / BOARD OF TRUSTEE1.00.0Yes (X)$0$0$0
Jee Youngmee
DIRECTOR / BOARD OF TRUSTEE1.00.0Yes (X)$0$0$0
Ros-Mari Balow
DIRECTOR / BOARD OF TRUSTEE1.00.0Yes (X)$0$0$0
Balram Bhargava
DIRECTOR / BOARD OF TRUSTEE1.00.0Yes (X)$0$0$0
Phil Driver
Deputy Dir. Gen of Fin & Ops40.00.0$338,472$0$2,811Yes (X)
Julia Lynch
Deputy Dir. Gen of Dev & delvy40.00.0$416,845$0$87,433Yes (X)
Sushant Sahastrabuddhe
Program Director, Typhoid40.00.0$200,002$0$4,902Yes (X)
Viliam Pavliak
Head of Vaccine Process Dev40.00.0$250,047$0$67,860Yes (X)
Yun Chon
Head of Biostatistics & Data40.00.0$223,113$0$53,654Yes (X)
Kyung-Taik Han
Deputy Dir. Gen of Gov Affairs40.00.0$218,773$0$1,217Yes (X)
Tobin Guarnacci
Head of Quality Management40.00.0$190,239$0$42,056Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$2,470,171TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$413,347TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K33IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp

Contractor Name ContractorName

FieldValueIRS element (for citing)
PersonThe Boston Consulting Group IncPersonNm

Contractor Address ContractorAddress

US Address USAddress

FieldValueIRS element (for citing)
Address Line1PO box 75200AddressLine1Txt
CityCHICAGOCityNm
State AbbreviationILStateAbbreviationCd
ZIP606755200ZIPCd
FieldValueIRS element (for citing)
ServicesCONSULTINGServicesDesc
Compensation$490,011CompensationAmt
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K1CntrctRcvdGreaterThan100KCnt
Fundraising$12,424FundraisingAmt
Government Grants$7,146,738GovernmentGrantsAmt
All Other Contributions$22,449,574AllOtherContributionsAmt
Noncash Contributions$26,338NoncashContributionsAmt
Total Contributions$29,608,736TotalContributionsAmt
Total Program Service Revenue$0TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$185,544TotalRevenueColumnAmt
Exclusion$185,544ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$0FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$12,424ContriRptFundraisingEventAmt
Fundraising Direct Expenses$532FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$532TotalRevenueColumnAmt
Exclusion-$532ExclusionAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$0GrossSalesOfInventoryAmt
Cost Of Goods Sold$0CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtExclusionExclusionAmt
MISCELLANEOUS REVENUE900099$131,763$131,763
RENTAL FOR ANIMAL ROOM900099$25,192$25,192
RENTAL FOR RESEARCH COLLABORATION900099$316,108$316,108
FieldValueIRS element (for citing)
Other Revenue Total$473,063OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$30,266,811TotalRevenueColumnAmt
Exclusion$658,075ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$712,234TotalAmt
Program Services$712,234ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$8,281,089TotalAmt
Program Services$8,281,089ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$5,023,172TotalAmt
Program Services$2,283,403ProgramServicesAmt
Management And General$2,639,767ManagementAndGeneralAmt
Fundraising$100,002FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$4,819,036TotalAmt
Program Services$3,393,960ProgramServicesAmt
Management And General$1,280,137ManagementAndGeneralAmt
Fundraising$144,939FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$604,200TotalAmt
Program Services$381,872ProgramServicesAmt
Management And General$202,524ManagementAndGeneralAmt
Fundraising$19,804FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$292,738TotalAmt
Program Services$151,487ProgramServicesAmt
Management And General$135,554ManagementAndGeneralAmt
Fundraising$5,697FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$154,695TotalAmt
Program Services$95,128ProgramServicesAmt
Management And General$54,188ManagementAndGeneralAmt
Fundraising$5,379FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$144,869TotalAmt
Program Services$46,699ProgramServicesAmt
Management And General$98,170ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$70,597TotalAmt
Program Services$14,938ProgramServicesAmt
Management And General$55,659ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$1,938,617TotalAmt
Program Services$1,417,442ProgramServicesAmt
Management And General$409,472ManagementAndGeneralAmt
Fundraising$111,703FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$406,892TotalAmt
Program Services$312,773ProgramServicesAmt
Management And General$84,114ManagementAndGeneralAmt
Fundraising$10,005FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$614,726TotalAmt
Program Services$530,633ProgramServicesAmt
Management And General$80,038ManagementAndGeneralAmt
Fundraising$4,055FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$1,578,828TotalAmt
Program Services$44,318ProgramServicesAmt
Management And General$1,534,510ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,608,892TotalAmt
Program Services$1,282,312ProgramServicesAmt
Management And General$324,939ManagementAndGeneralAmt
Fundraising$1,641FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$358,648TotalAmt
Program Services$280,502ProgramServicesAmt
Management And General$60,467ManagementAndGeneralAmt
Fundraising$17,679FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$243,262TotalAmt
Program Services$0ProgramServicesAmt
Management And General$243,262ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$56,093TotalAmt
Program Services$14,075ProgramServicesAmt
Management And General$41,134ManagementAndGeneralAmt
Fundraising$884FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmt
LAB SUPPLIES$1,553,547$1,531,419$22,128
REPAIRS AND MAINTENANCE$63,762$11,560$52,202
TRAINING$15,647$7,577$8,070
ALLOCATION OF INDIRECT COSTS$2,435,098-$2,435,098

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$44,529TotalAmt
Program Services$11,149ProgramServicesAmt
Management And General$29,882ManagementAndGeneralAmt
Fundraising$3,498FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$28,586,073TotalAmt
Program Services$23,239,668ProgramServicesAmt
Management And General$4,921,119ManagementAndGeneralAmt
Fundraising$425,286FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$19,061,316BOYAmt
EOY$18,458,926EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$81,190BOYAmt
EOY$443,355EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$24,709BOYAmt
EOY$50,718EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$140,545BOYAmt
EOY$33,994EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$102,974BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$229,986BOYAmt
EOY$271,305EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$7,992,082LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$6,334,826LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$1,271,373BOYAmt
EOY$1,657,256EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$4,246BOYAmt
EOY$293,276EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$20,916,339BOYAmt
EOY$21,208,830EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$1,469,522BOYAmt
EOY$1,508,413EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$11,557,615BOYAmt
EOY$10,576,991EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$1,016,551BOYAmt
EOY$712,641EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$14,043,688BOYAmt
EOY$12,798,045EOYAmt
FieldValueIRS element (for citing)
Org Does Not Follow SFAS117Yes (X)OrgDoesNotFollowSFAS117Ind

Cap Stk Tr Prin Current Funds CapStkTrPrinCurrentFundsGrp

FieldValueIRS element (for citing)
BOY$4,160,489BOYAmt
EOY$5,698,623EOYAmt

Pd In Cap Srpls Land Bldg Eqp Fund PdInCapSrplsLandBldgEqpFundGrp

FieldValueIRS element (for citing)
BOY$2,712,162BOYAmt
EOY$2,712,162EOYAmt

Rtn Earn Endowment Incm Oth Fnds RtnEarnEndowmentIncmOthFndsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$6,872,651BOYAmt
EOY$8,410,785EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$20,916,339BOYAmt
EOY$21,208,830EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$1,680,738ReconcilationRevenueExpnssAmt
Other Changes In Net Assets-$142,604OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$23,508,996CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$21,104,491CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$25,948,268CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$27,484,411CurrentTaxYearMinus1YearAmt
Current Tax Year$29,608,736CurrentTaxYearAmt
Total$127,654,902TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$23,508,996CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$21,104,491CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$25,948,268CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$27,484,411CurrentTaxYearMinus1YearAmt
Current Tax Year$29,608,736CurrentTaxYearAmt
Total$127,654,902TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$51,727,093SubstantialContributorsTotAmt
Public Support Total170$75,927,809PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$72,912CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$35,005CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$49,021CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$76,238CurrentTaxYearMinus1YearAmt
Current Tax Year$185,544CurrentTaxYearAmt
Total$418,720TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$28,581CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$15,859CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$63,086CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$235,735CurrentTaxYearMinus1YearAmt
Current Tax Year$473,063CurrentTaxYearAmt
Total$816,324TotalAmt
FieldValueIRS element (for citing)
Total Support$128,889,946TotalSupportAmt
Gross Receipts Rltd Activities$7,075GrossReceiptsRltdActivitiesAmt
Public Support CY1700.58909PublicSupportCY170Pct
Public Support PY1700.58478PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp
CY Minus3 Yr Endwmt FundCYMinus3YrEndwmtFundGrp
CY Minus4 Yr Endwmt FundCYMinus4YrEndwmtFundGrp
LandLandGrp
BuildingsBuildingsGrp
Leasehold ImprovementsLeaseholdImprovementsGrp

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$7,948,718OtherCostOrOtherBasisAmt
Depreciation$6,326,876DepreciationAmt
Book Value$1,621,842BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$43,364OtherCostOrOtherBasisAmt
Depreciation$7,950DepreciationAmt
Book Value$35,414BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$1,657,256TotalBookValueLandBuildingsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
ADVANCE FUND FROM SIDA$522,400
SECURITY DEPOSIT$190,241
FieldValueIRS element (for citing)
Total Liability$712,641TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$30,267,343TotalRevEtcAuditedFinclStmtAmt
Revenue Subtotal$30,267,343RevenueSubtotalAmt
Other Revenues Not Included-$532OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt-$532RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$30,266,811TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$28,586,605TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$532OtherExpensesIncludedAmt
Expenses Not Reported$532ExpensesNotReportedAmt
Expenses Subtotal$28,586,073ExpensesSubtotalAmt
Total Expenses Per Form990$28,586,073TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Part XI, Line 4B:Cost of Goods Sold -$532
Part XII, Line 2D:Cost of Goods Sold $532

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (4 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
East Asia and the Pacific1131Program ServicesProgram Service$6,768,510
Europe (Including Iceland and Greenland)Grantmaking$739,223
South AsiaGrantmaking$4,375
Sub-Saharan AfricaGrantmaking$768,982
FieldValueIRS element (for citing)
Subtotal Offices1SubtotalOfficesCnt
Subtotal Employees131SubtotalEmployeesCnt
Total Office1TotalOfficeCnt
Total Employee131TotalEmployeeCnt
Subtotal Spent$8,281,090SubtotalSpentAmt
Total Spent$8,281,090TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (31 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxt
East Asia and the PacificProgram Service$1,952,925WIRE
East Asia and the PacificProgram service$1,558,350WIRE
East Asia and the PacificProgram service$637,271WIRE
East Asia and the PacificProgram service$540,966WIRE
East Asia and the PacificProgram service$470,882WIRE
East Asia and the PacificProgram service$343,290WIRE
Europe (Including Iceland and Greenland)Program service$324,464WIRE
East Asia and the PacificProgram service$269,752WIRE
East Asia and the PacificProgram service$253,318WIRE
East Asia and the PacificProgram service$247,700WIRE
East Asia and the PacificProgram service$241,480WIRE
Europe (Including Iceland and Greenland)Program service$172,766WIRE
Sub-Saharan AfricaProgram service$169,112WIRE
Sub-Saharan AfricaProgram service$142,027WIRE
Sub-Saharan AfricaProgram service$137,574WIRE
Europe (Including Iceland and Greenland)Program service$132,043WIRE
Sub-Saharan AfricaProgram service$110,288WIRE
Europe (Including Iceland and Greenland)Program service$109,708WIRE
Sub-Saharan AfricaProgram service$80,000WIRE
Sub-Saharan AfricaProgram service$73,101WIRE
East Asia and the PacificProgram service$70,000WIRE
East Asia and the PacificProgram service$44,000WIRE
Sub-Saharan AfricaProgram service$36,940WIRE
East Asia and the PacificProgram service$30,000WIRE
East Asia and the PacificProgram service$28,113WIRE
East Asia and the PacificProgram service$22,559WIRE
East Asia and the PacificProgram service$21,433WIRE
East Asia and the PacificProgram service$15,937WIRE
East Asia and the PacificProgram service$9,690WIRE
Sub-Saharan AfricaProgram service$8,544WIRE
Sub-Saharan AfricaProgram service$8,050WIRE
FieldValueIRS element (for citing)
Total501c3 Org31Total501c3OrgCnt
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceMONITORING GRANTS OUTSIDE THE USFormAndLineReferenceDesc
ExplanationTHE IVI IS LOCATED IN SEOUL, KOREA WHERE ALL THE GRANT FUNDS ARE MANAGED AND EXECUTED. THE IVI HAS IN PLACE A VERY DETAILED AND RIGOROUS SYSTEM OF FINANCIAL MONITORING. THIS SYSTEM, WHICH IS EVALUATED BY INTERNAL FINANCE PERSONNEL THROUGHOUT THE YEAR AND AUDITED EXTERNALLY EVERY YEAR, IS USED IN CONJUNCTION WITH CAREFUL PROJECT DEVELOPMENT AND IMPLEMENTATION TO ENSURE ACCOUNTABILITY AND BUDGETARY MANAGEMENT RESPONSIBILITY. FOR SUBGRANTS, THE IVI HAS A BROAD OVERALL SYSTEM OF REVIEWING AND TRACKING THE USE OF GRANTS, AND MORE SPECIFIC DAY-To-DAY REVIEW PROCESSES, WHICH INCLUDE THE FOLLOWING: -REVIEWS OF FINANCIAL AND NARRATIVE REPORTS, AUDIT REPORTS, CORRESPONDENCE AND OTHER DOCUMENTATION PROVIDED BY THE GRANTEES -DIRECT COMMUNICATION WITH GRANTEES THROUGH TELEPHONE AND EMAIL FOR QUESTIONS AND TO CHECK ON PROGRESS OF THE PROJECT -ON-SITE VISITS TO THE FIELD SITES TO REVIEW ONE OR MORE ASPECTS OF THE PROJECTS -MONITORING THROUGH AN EXTERNAL AUDIT. A CERTAIN NUMBER OF SUB-GRANTEES ARE SELECTED FOR THE AUDIT EACH YEAR, WHICH IS DONE TO ENSURE FINANCIAL AND EXPENDITURE COMPLIANCE WITH THE RESEARCH AGREEMENT.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (4 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
Child Health Research Foundation
1 N LEXINGTON AVEWHITE PLAINSNY10601272415391501(c)(3)$66,482Program service
INC Research LLC
3201 BEECHLEAF CT STE 600RALEIGHNC27604330723120$178,532PROGRAM SERVICE
Innovations for Global Health
3240 HURON PEAK AVESUPERIORCO80027201059464501(C)(3)$141,150PROGRAM SERVICE
MPI Research Inc
54943 N MAIN STREETMATTAWANMI49071383400587$326,070PROGRAM SERVICE
FieldValueIRS element (for citing)
Total501c3 Org2Total501c3OrgCnt
Total Other Org2TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceMONITORING USE OF GRANTSFormAndLineReferenceDesc
ExplanationTHE IVI IS LOCATED IN SEOUL, KOREA WHERE ALL THE GRANT FUNDS ARE MANAGED AND EXECUTED. THE IVI HAS IN PLACE A VERY DETAILED AND RIGOROUS SYSTEM OF FINANCIAL MONITORING. THIS SYSTEM, WHICH IS EVALUATED BY INTERNAL FINANCE PERSONNEL THROUGHOUT THE YEAR AND AUDITED EXTERNALLY EVERY YEAR, IS USED IN CONJUNCTION WITH CAREFUL PROJECT DEVELOPMENT AND IMPLEMENTATION TO ENSURE ACCOUNTABILITY AND BUDGETARY MANAGEMENT RESPONSIBILITY. FOR SUBGRANTS, THE IVI HAS A BROAD OVERALL SYSTEM OF REVIEWING AND TRACKING THE USE OF GRANTS, AND MORE SPECIFIC DAY-To-DAY REVIEW PROCESSES, WHICH INCLUDE THE FOLLOWING: -REVIEWS OF FINANCIAL AND NARRATIVE REPORTS, AUDIT REPORTS, CORRESPONDENCE AND OTHER DOCUMENTATION PROVIDED BY THE GRANTEES -DIRECT COMMUNICATION WITH GRANTEES THROUGH TELEPHONE AND EMAIL FOR QUESTIONS AND TO CHECK ON PROGRESS OF THE PROJECT -ON-SITE VISITS TO THE FIELD SITES TO REVIEW ONE OR MORE ASPECTS OF THE PROJECTS -MONITORING THROUGH AN EXTERNAL AUDIT. A CERTAIN NUMBER OF SUB-GRANTEES ARE SELECTED FOR THE AUDIT EACH YEAR, WHICH IS DONE TO ENSURE FINANCIAL AND EXPENDITURE COMPLIANCE WITH THE RESEARCH AGREEMENT.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Travel For CompanionsYes (X)TravelForCompanionsInd
Idemnification Gross Up PmtsYes (X)IdemnificationGrossUpPmtsInd
Housing Allowance Or ResidenceYes (X)HousingAllowanceOrResidenceInd
Personal ServicesYes (X)PersonalServicesInd
Written Policy Ref T And E ExpnssYes (true)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (true)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (8 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Jerome Kim
Director General$311,278$0$28,987$0$278,383$0$142,092$0$11,322$0$772,062$0$0$0
Julia Lynch
Deputy Dir. Gen of Dev & delvy$225,390$0$0$0$191,455$0$82,947$0$4,486$0$504,278$0$0$0
Phil Driver
Deputy Dir. Gen of Fin & Ops$258,005$0$0$0$80,467$0$0$0$2,811$0$341,283$0$0$0
Sushant Sahastrabuddhe
Program Director, Typhoid$112,324$0$0$0$87,678$0$0$0$4,902$0$204,904$0$0$0
Viliam Pavliak
Head of Vaccine Process Dev$176,868$0$0$0$73,179$0$65,470$0$2,390$0$317,907$0$0$0
Yun Chon
Head of Biostatistics & Data$147,220$0$0$0$75,893$0$52,437$0$1,217$0$276,767$0$0$0
Kyung-Taik Han
Deputy Dir. Gen of Gov Affairs$187,765$0$0$0$31,008$0$0$0$1,217$0$219,990$0$0$0
Tobin Guarnacci
Head of Quality Management$120,000$0$0$0$70,239$0$31,625$0$10,431$0$232,295$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceCOMPENSATIONFormAndLineReferenceDesc
ExplanationTRAVEL FOR COMPANION: AFTER 15 MONTHS OF SERVICE, THE INTERNATIONALLY RECRUITED STAFF IS ENTITLED TO HOME LEAVE TRAVEL. THIS ENTITLEMENT IS AN ECONOMY ROUND TRIP BETWEEN DUTY STATION AND HOME BASE FOR STAFF, SPOUSE AND DEPENDENTS UNDER 21. TAX INDEMNIFICATION AND GROSS UP PAYMENTS: IN ORDER TO EQUALIZE THE BENEFITS ACCRUED TO INTERNATIONALLY RECRUITED STAFF, IVI COMPENSATES STAFF WHO ARE OBLIGATED TO PAY TAXES ON IVI DERIVED INCOME TO THEIR HOME COUNTRY. ANY TAX SUBSEQUENTLY LEVIED ON THE AMOUNT OF THE REIMBURSEMENT IS NOT REIMBURSED. IN GENERAL, THIS IS TREATED AS TAXABLE COMPENSATION. HOUSING ALLOWANCE: IVI PROVIDES INTERNATIONALLY RECRUITED STAFF IN KOREA WITH A HOUSING ALLOWANCE UP TO 75% OF A CEILING THAT IS ESTABLISHED AND REVIEWED PERIODICALLY. PERSONAL SERVICES (I.E. DRIVER): IVI PROVIDES THE DIRECTOR GENERAL WITH A DRIVER WHICH IS INCLUDED IN HIS/HER EMPLOYMENT CONTRACT PACKAGE APPROVED BY THE BOARD OF TRUSTEES.ExplanationTxt

Schedule L IRS990ScheduleL

Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp (5 entries)

Relationship With OrgRelationshipWithOrgTxtLoan PurposeLoanPurposeTxtLoan From OrganizationLoanFromOrganizationIndOriginal PrincipalOriginalPrincipalAmtBalance DueBalanceDueAmtDefaultDefaultIndBoard Or Committee ApprovalBoardOrCommitteeApprovalIndWritten AgreementWrittenAgreementInd
JEROME KIM
EMPLOYEEEDUCATIONYes (X)$16,964$11,309falseYes (true)Yes (true)
TOBIN GUANACCI
EMPLOYEEEDUCATIONYes (X)$12,745$8,497falseYes (true)Yes (true)
ARIJIT SIL
EMPLOYEEEDUCATIONYes (X)$10,583$4,209falseYes (true)Yes (true)
SATYANARAYANA BEJJANI
EMPLOYEEEDUCATIONYes (X)$18,363$6,907falseYes (true)Yes (true)
ANH WARTEL
EMPLOYEEEDUCATIONYes (X)$4,743$3,072falseYes (true)Yes (true)
FieldValueIRS element (for citing)
Total Balance Due$33,994TotalBalanceDueAmt

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp
Clothing And Household GoodsClothingAndHouseholdGoodsGrp
Cars And Other VehiclesCarsAndOtherVehiclesGrp
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp
Securities Publicly TradedSecuritiesPubliclyTradedGrp
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp
Food InventoryFoodInventoryGrp
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp

Other Non Cash Contri Table OtherNonCashContriTableGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
DescROK EQUIPMENTDesc
Contribution1ContributionCnt
Noncash Contributions Rpt F990$26,338NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 25, COLUMN (B):FormAndLineReferenceDesc
ExplanationTHE ORGANIZATION REPORTS THE NUMBER OF CONTRIBUTIONS RECEIVED.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (12 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART I, LINE 1:IVI'S MISSION IS TO DISCOVER, DEVELOP AND DELIVER SAFE, EFFECTIVE AND AFFORDABLE VACCINES FOR THE WORLD'S DEVELOPING NATIONS. ITS VISION IS DEVELOPING COUNTRIES FREE OF SUFFERING FROM INFECTIOUS DISEASE.
FORM 990, PART III, LINE 1:IVI IS THE ONLY INTERNATIONAL ORGANIZATION IN THE WORLD EXCLUSIVELY DEDICATED TO DISCOVERING, DEVELOPING AND DELIVERING VACCINES FOR GLOBAL HEALTH. IVI FOCUSES ON VACCINES AGAINST INFECTIOUS DISEASES OF THE MOST IMPOVERISHED. WE AIM TO MAKE VACCINES AVAILABLE AND ACCESSIBLE FOR VULNERABLE POPULATIONS IN DEVELOPING COUNTRIES. WE LIVE IN AN INCREASINGLY GLOBALIZED WORLD WHERE NEW AND EMERGING INFECTIOUS DISEASES CAN BECOME GLOBAL HEALTH THREATS. IVI ALSO FOCUSES ON VACCINES AGAINST INFECTIOUS DISEASES OF MAJOR GLOBAL HEALTH CONCERN. OUR RESEARCH SPANS THE ENTIRE VACCINE SPECTRUM FROM DISCOVERY AND PRECLINICAL DEVELOPMENT IN OUR SEOUL-BASED LABS TO CLINICAL DEVELOPMENT AT FIELD SITES IN DEVELOPING COUNTRIES TO GENERATING SCIENTIFIC EVIDENCE ON THE NEED FOR VACCINATION IN COUNTRIES WHERE VACCINES ARE MOST NEEDED. OUR HEADQUARTERS IN SEOUL HAVE STATE-OF-THE ART LAB FACILITIES, ANIMAL HOUSE, AND RESEARCH TEAMS THAT INCLUDE CLINICAL IMMUNOLOGY, PROCESS DEVELOPMENT, EPIDEMIOLOGY, CLINICAL & REGULATORY, BIOSTATISTICS & DATA MANAGEMENT, AND POLICY & ECONOMIC RESEARCH. OUTSIDE OF SEOUL, WE HAVE A GLOBAL NETWORK OF FIELD SITES IN MORE THAN 20 COUNTRIES IN ASIA, AFRICA, AND THE AMERICAS. WE MANAGE FIELD SITES IN COLLABORATION WITH REGIONAL AND IN-COUNTRY PARTNERS. WE WORK WITH LOCAL PARTNERS TO IMPLEMENT TRANSLATIONAL AND FIELD RESEARCH PROJECTS, AND WE ALSO PROVIDE TRAINING AND TECHNICAL ASSISTANCE.
FORM 990, PART III, LINE 2:THAILAND HPV VACCINE SINGLE DOSE IMPACT STUDY. A NEW GRANT HAS BEEN AWARDED (APRIL 2018) BY BMGF (USD 6,465,515) OVER THE 66-MONTH PERIOD TO CONDUCT AN EFFECTIVENESS STUDY COMPARING THE IMPACT OF THE WHO RECOMMENDED TWO DOSE REGIMEN OF HPV VACCINE TO A SINGLE DOSE REGIMEN IN TWO PROVINCES IN THAILAND OVER THE 66-MONTH PERIOD. FOLLOWING AWARD OF THE GRANT, A KICK-OFF MEETING WAS HELD IN BANGKOK ON APRIL 18-19, 2018 TO BRING ALL COLLABORATORS (THE THAI MINISTRY OF PUBLIC HEALTH, DEPARTMENT OF DISEASE CONTROL, CHULALONGKORN UNIVERSITY IN BANGKOK, AND THE US-CDC) TOGETHER TO ALIGN ON THE PROJECT PLAN AND TIMELINE AND ESTABLISH WORKING GROUPS TO ADVANCE THE STUDY PLANS AND PROTOCOL. A STUDY STEERING COMMITTEE (SSC) WAS FORMED AMONG THE SENIOR SCIENTISTS FROM THE COLLABORATING ORGANIZATIONS IN ORDER TO ENSURE AN EFFECTIVE MECHANISM FOR COMMUNICATION, RISK MANAGEMENT AND ISSUE RESOLUTION AMONG THE PARTNERS. THROUGHOUT THE SUMMER AND FALL OF 2018 THE WORK PLAN DEVELOPMENT OF THE DIFFERENT WORKING GROUPS WAS INTEGRATED INTO CLINICAL PROTOCOLS AND FINAL WORK PLANS. PREPARATORY ACTIVITIES ALSO OCCURRED IN PARALLEL AT THE CHULALONGKORN LABORATORY INCLUDING REMODELING AND EQUIPPING OF A NEW DEDICATED LAB SPACE FOR COBAS TESTING, TRAINING OF LABORATORY STAFF, ENHANCEMENT OF THE QUALITY SYSTEM, AND COMPLETION OF A TEST METHOD EVALUATION. THE CHULALONGKORN LABORATORY FURTHER UNDERWENT AN AUDIT BY THE IVI QUALITY ASSURANCE UNIT (DECEMBER 2018) PRIOR TO INITIATION OF SAMPLE TESTING. PROTOCOL APPROVALS WERE FINALLY RECEIVED FROM THAILAND MOPH EC (NOVEMBER 29, 2018), CHULALONGKORN UNIVERSITY IRB (DECEMBER 4, 2018) AND THE IVI IRB (DECEMBER 13, 2018) THUS COMPLETING STUDY PREPARATORY ACTIVITIES ON DECEMBER 13, 2018. ENROLLMENT OF SUBJECTS WAS INITIATED ON DECEMBER 17, 2018, ALL VACCINATIONS (N=15,818) AND ALL BASELINE SURVEY ENROLLMENTS INCLUSIVE OF A URINE SPECIMEN (N= 8,588) WERE COMPLETED BY MARCH 4, 2019.
FORM 990, PART III, LINE 3:SHANCHOL, ORAL cholera VACCINE MODIFIED AND TECHNOLOGY-TRANSFERRED BY IVI IN 2008, WAS LICENSED IN INDIA IN 2009. POST LICENSURE, SEVERAL QUESTIONS REMAINED TO BE ANSWERED CRITICAL FOR VACCINE DEVELOPMENT. IVI PROPOSED A SERIES OF STUDIES THAT WOULD EXPAND THE EVIDENCE-BASED CRITICAL INFORMATION FOR USE OF OPTIMAL DOSING REGIMEN. THE GRANT WITH FOUR OBJECTIVES WAS AWARDED BY THE FOUNDATION IN OCTOBER 2009 AND CONTINUED UNTIL DECEMBER 2017. INITIAL APPROVED GRANT WAS $7,507,377 FOR 47 MONTHS FROM AUGUST 2013. IN 2012, THE BUDGET FOR SINGLE DOSE INCREASED DRASTICALLY DUE TO AN INCREASE OF SAMPLE SIZE (FROM -85,000 TO -155,000) OF THE STUDY. THEREFORE, WE REQUESTED TO TRANSFER THE BALANCE FUND OF PHASE III EXT. GRANT (1005560), CHOVI GRANT (38590) AND CHOZAN GRANT (760606) TO THE SINGLE DOSE TRIAL. THE MASTER AMENDMENT DATED JANUARY 24, 2014 ALLOWED THIS TRANSFER. CONSEQUENTLY, TOTAL GRANT AMOUNT HAS BEEN INCREASED FROM $7,507,377 TO $14,121,679. IN YEAR 7, WITH PERIOD EXTENSION, WE RECEIVED THE SUPPLEMENTAL FUNDING ($309,260) TO COVER REVACCINATION. INCLUDING THIS SUPPLEMENT FUNDING, THE TOTAL GRANT INCREASED TO $13,430,939. THROUGH THE ENTIRE GRANT PERIOD, WE RECEIVED A TOTAL OF $13,430,938.
FORM 990, PART V, LINES 1A AND 2A:IVI'S HEADQUARTERS IS BASED IN SEOUL, KOREA. SINCE THE ORGANIZATION IS NOT UNITED STATES BASED, THE ORGANIZATION HAS ONLY FILED (1) FORM W-2 FOR AN EMPLOYEE RESIDING IN THE UNITED STATES. AS OF DECEMBER 31, 2018, THE ORGANIZATION REPORTS 131 EMPLOYEES.
FORM 990, PART V, LINE 4:IVI is a foreign organization. It is not required to file Form FinCEN 114 (Report of Foreign Bank and Financial Accounts).
FORM 990, PART VI, LINE 7A:Director General of the Institute is also a voting member of the Board; thus, he/she can participate in the election of the Board.
FORM 990, PART VI, LINE 11B:The finance team makes a first draft of form 990 and the related schedules. HR provides specific information on compensation and other teams provide fundraising, governance and management information. Public accountant prepares the return on IVI's behalf and this is reviewed in turn by the COO and Deputy CFO for accuracy.
FORM 990, PART VI, LINE 12C:THE IVI HR PROVIDES A COPY OF THE CONFLICT OF INTEREST POLICY TO ALL DIRECTORS, OFFICERS AND STAFF TO COMPLETE ANNUALLY. NOT ONLY PERSONS WITH ACTUAL OR POTENTIAL CONFLICTS OF INTEREST BUT ALSO PERSONS WHO DO NOT HAVE ANY CONFLICTS OF INTEREST MUST SUBMIT A SIGNED COPY OF THE DISCLOSURE OF ACTUAL OR POTENTIAL CONFLICTS OF INTEREST TO THE IVI BOARD SECRETARIAT OR THE IVI HUMAN RESOURCES UNIT AS APPROPRIATE. THE CONFLICT COORDINATOR (DIRECTOR GENERAL) CREATES A CONFLICT COMMITTEE COMPOSED OF THREE OTHER MEMBERS OF THE IVI STAFF TO REVIEW CONFLICT OF INTEREST ISSUES THAT MAY ARISE. THE CONFLICT COMMITTEE SHALL BE RESPONSIBLE FOR ENSURING THAT RELEVANT CONFLICTS OF INTEREST, AND THE PROCEDURES TAKEN TO ELIMINATE, REDUCE OR MANAGE THOSE CONFLICTS, ARE DISCLOSED AT OR PRIOR TO ANY BOARD OF TRUSTEES MEETING. THE COMMITTEE SHALL KEEP A RECORD OF ALL ACTUAL AND POTENTIAL CONFLICTS OF INTEREST AND REPORT ANNUALLY THEREON TO THE BOARD OF TRUSTEES. IN CASE OF TRUSTEES, IVI BOARD SECRETARIAT PROVIDES A COPY OF THE CONFLICT OF INTEREST POLICY TO THE MEMBERS WHEN THEY FIRST JOIN, ALL MEMBERS MUST SUBMIT A SIGNED COPY OF THE DISCLOSURE OF ACTUAL AND POTENTIAL CONFLICTS OF INTEREST TO IVI. THE MEMBERS SHOULD REPORT THEIR CHANGES OF STATUS TO THE BOARD SECRETARIAT.
FORM 990, PART VI, LINES 15A and 15B:THE IVI UNDERTAKES A COMPREHENSIVE COMPENSATION STUDY FOR ITS OFFICERS AND KEY EMPLOYEES. A COMPENSATION CONSULTANT CONDUCTS THE STUDY AND LOOKS AT COMPENSATION AMONG COMPARABLE ORGANIZATIONS WITH SIMILAR POSITIONS AND RESPONSIBILITIES IN ORDER TO PROVIDE MARKET DATA TO DETERMINE IVI STAFF MEMBER COMPENSATION. COMPENSATION IS SET BY INDEPENDENT PERSONS, AND CONTEMPORANEOUS DOCUMENTATION OF THE PROCESS IS RETAINED.
FORM 990, PART VI, LINE 19:The IVI's governing documents-Establishment Agreement, Headquarters Agreement, Constitution and Amendments to the Constitution are available on IVI's website. The Summary of financial report is included in IVI's Annual report.
FORM 990, PART XI, LINE 9:FOREIGN CURRENCY EXCHANGE LOSS -$142,604

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.